SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

Alpha Capital Acquisition Co (ASPC) is experiencing significant market attention, fueled by its extremely low share float and a reported high short interest. The trading community is actively discussing a potential short squeeze and anticipating substantial upward price movement, frequently drawing parallels to other recent volatile low-float SPAC runners. However, some market participants advise caution, referencing the stock's historical tendency for rapid gains followed by sell-offs.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is trending after its experimental depression treatment, BHV-7000, failed to meet its primary endpoint in a Phase 2 study, leading the company to halt further psychiatric trials for the drug. Despite the setback, which analysts widely deemed "disappointing but not surprising," community focus is now strongly shifting to the company's broader pipeline, especially upcoming pivotal data for its epilepsy program and other key immunology and obesity assets.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining Inc. is a key discussion point following its strategic $7 billion acquisition of New Gold, positioning it as a major North American precious metals producer amidst a strong bull market for gold and silver. The community is actively discussing CDE's robust Q3 earnings and silver's record highs, with many anticipating significant upside as institutional interest grows in the mining sector.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is facing intense scrutiny and widespread community backlash following a massive data breach affecting millions of users, with discussions heavily focused on the company's response and its CEO's perceived lack of accountability in South Korea. This has triggered calls for boycotts and potential multi-billion dollar lawsuits, even as some investors eye the stock as an oversold opportunity, weighing its market dominance against significant regulatory and consumer trust challenges.

ProShares Trust - ProShares UltraShort Silver -2x Shares

ProShares UltraShort Silver

ProShares UltraShort Silver ($ZSL) is trending as the community hotly debates the sustainability of silver's recent rally, with many anticipating a significant pullback for the metal. Traders are actively initiating or adding to short positions, betting that silver is overbought and due for a correction, citing the historical tendency of parabolic moves to reverse. However, some caution against shorting precious metals in the current macro environment, highlighting the inherent risks and historical underperformance of inverse leveraged ETFs over time.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petroleo Brasileiro is trending due to rapidly escalating geopolitical tensions in the Middle East, which are propelling oil prices higher and intensifying market interest in energy producers. The community is actively discussing PBR's unique position as an undervalued oil major operating in a non-conflict region, prompting expectations for strong performance and continued attractive dividends.

OpGen, Inc. is a precision medicine company, which engages in the power of molecular diagnostics and informatics to help combat infectious disease. It focuses on the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Clarksburg, MD.

Opgen Inc

Opgen Inc. (OPGN OTC) is seeing significant community discussion as investors react to recent corporate filings, including the extension of a key stock purchase agreement, bolstering hopes for the company's strategic pivot. The community is eagerly anticipating a potential Nasdaq relisting and the full launch of its AI-driven CapForce fintech platform, driving speculative conversations around a major turnaround and future valuation.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is generating considerable excitement due to multiple impending FDA decisions, including Tradipitant for motion sickness and GLP-1 induced nausea, Hetlioz for jet lag following a successful court appeal, and Bysanti for psychiatric disorders. The community is actively discussing the substantial revenue potential from these pipeline catalysts, particularly Tradipitant's entry into the massive GLP-1 market, viewing the stock as significantly undervalued. This confluence of regulatory events and a strong pipeline fuels bullish sentiment, with many anticipating significant upside potential and the possibility of renewed buyout interest.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies Inc

Voyager Technologies is trending following a significant $21 million Air Force Research Lab contract win for AI-enabled ISR systems, alongside ongoing anticipation for its Starlab Critical Design Review and potential NASA Phase 2 awards. Investors are sharply divided, with bulls highlighting its "vertically integrated space + defense platform" and "asymmetric upside," while skeptics point to considerable price volatility and question its valuation compared to peers in the burgeoning space sector.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

ExxonMobil is trending following its upgraded long-term earnings and cash flow outlook, amplified by escalating geopolitical tensions around Venezuelan oil impacting global supply. The community is actively discussing the company's impressive operational resilience, driven by strong performance in key assets and consistent shareholder returns amidst volatile energy markets. This reinforces XOM's appeal as a stable energy play, especially with new demand catalysts emerging from sectors like AI data centers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Raub Brock Capital Management LP Buys 10,533 Shares of Zoetis Inc. $ZTS

Raub Brock Capital Management LP lifted its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 12.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC...

Covea Finance Sells 22,300 Shares of Zoetis Inc. $ZTS

Covea Finance decreased its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 7.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The...

AMI Asset Management Corp Sells 12,087 Shares of Zoetis Inc. $ZTS

AMI Asset Management Corp cut its holdings in Zoetis Inc. (NYSE:ZTS - Free Report) by 3.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The...

FY2026 Earnings Forecast for Zoetis Issued By Zacks Research

Zoetis Inc. (NYSE:ZTS - Free Report) - Investment analysts at Zacks Research dropped their FY2026 earnings per share (EPS) estimates for shares of Zoetis in a report released on Tuesday, December...

Cornercap Investment Counsel Inc. Takes $1.60 Million Position in Zoetis Inc. $ZTS

Cornercap Investment Counsel Inc. purchased a new stake in Zoetis Inc. (NYSE:ZTS - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange...

Zoetis Inc. $ZTS Stock Holdings Decreased by Vontobel Holding Ltd.

Vontobel Holding Ltd. lessened its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 20.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional...

Zoetis Inc. $ZTS Shares Purchased by Swedbank AB

Swedbank AB raised its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 60.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange...

Trade Tracker: Stephanie Link buys mores Zoetis

Stephanie Link, CIO at Hightower, joins CNBC's 'Halftime Report' to explain why she's buying more Zoetis...

Medical Stocks To Watch Now - December 23rd

Novo Nordisk A/S, Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Zoetis are the seven Medical stocks to watch today, according to MarketBeat's stock...

Zoetis (ZTS) Outperforms Broader Market: What You Need to Know

Zoetis (ZTS) closed at $123.78 in the latest trading session, marking a +1.26% move from the prior day.

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Current Price	$125.49
Prev Close	$123.54
Open	$123.10
Dividend Yield	1.10%
50-Day Moving Average	$128.04
Beta	0.73
Avg. Volume	5.58M
PE Ratio	21.14

52-Week High	$177.40
52-Week Low	$115.25
Market Capitalization	$58.88B
EPS (Annual)	$5.47
Price to Book	10.26
Revenue Per Employee	$670,724.64
Enterprise Value/EBITDA	N/A

ZTS
Zoetis Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZTS News

ZTSZoetis Inc - Ordinary Shares - Class A